ArticleTropical medicine and health2026
Silent transmission of human African trypanosomiasis: isolation of a human-infective trypanosome from an asymptomatic pregnant woman in south-eastern Nigeria.
Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman African trypanosomiasis (HAT) is an endemic neglected tropical disease in Sub-Saharan Africa targeted for elimination by 2030. However, asymptomatic human infections may sustain cryptic transmission. Nigeria has not reported confirmed HAT cases in over a decade, but emerging evidence suggests ongoing silent transmission. Infection during pregnancy raises additional concerns, including adverse outcomes and vertical transmission. This study therefore investigated the presence of trypanosome infection in pregnant women attending the antenatal clinic in Enugu, Nigeria.
methodsPeripheral blood from pregnant women attending antenatal care in Enugu State, Nigeria, were screened microscopically for the presence of trypanosomes using the micro-haematocrit centrifugation technique. A sample containing motile organisms suggestive of Trypanosoma spp. was further investigated through rodent inoculation for parasite amplification, followed by morphologic identification, Blood Incubation Infectivity Test (BIIT), and in vitro culture. Serologic assays (ELISA and CATT) were conducted on patient serum, and a multiplex PCR targeting both Trypanosomatidae and Trypanozoon-specific regions of the 18S rDNA was done using DNA extracted from the patient's blood and from inoculated rats.
resultsThe pregnant woman was asymptomatic but mildly anaemic, with a history of recurrent miscarriage. Serum assay was positive by CATT but negative by ELISA. Parasitaemia was successfully established in experimentally infected rats, with Giemsa-stained smears showing long slender trypomastigotes consistent with the bloodstream form of the Trypanozoon complex. The isolate demonstrated resistance to human serum and established infection following BIIT, confirming human infectivity. In vitro culture yielded viable parasite populations. PCR amplified Trypanozoon-specific region of the 18S rDNA from both the inoculated rat and patient blood samples.
conclusionsThis study provides direct parasitological evidence of asymptomatic human trypanosome infection in Enugu State, Nigeria, a region not previously considered an HAT focus. These findings highlight the potential role of asymptomatic carriers in sustaining transmission and underscore critical gaps in surveillance, particularly in antenatal populations and undocumented foci. Enhanced active surveillance integrating sensitive diagnostic approaches is essential to achieving HAT elimination goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.